Company Overview
Sun Pharma is world’s fifth largest specialty generic and India’s top pharmaceutical company with global presence supported by 49 manufacturing facilities spread across 6 continents. Company has expanded both organically and through acquisitions (Caraco, Taro, Dusa, Ranbaxy). In India, Sun Pharma enjoys leadership across 12 different classes of doctors with 30 brands featuring amongst top 300 pharmaceutical brands. In Indian formulations, the company is a leader in niche therapy areas of psychiatry, gastroenterology, neurology, cardiology, nephrology, orthopaedics and ophthalmology. It covers more than 100 markets in emerging countries and six markets in Western Europe.
